Serina shareholders approve equity plan amendment increasing share reserve by 950,000 shares

Serina Therapeutics, Inc.

Shareholders approved Amendment to 2024 Equity Incentive Plan, increasing shares reserved by 950,000 to 2,675,000.
Amendment also provides for automatic annual share increase of 5% of outstanding shares from FY2026 through FY2034.
Directors elected: Balkrishan 'Simba' Gill (5,998,349 votes), Remy Gross (5,963,359), Steven Mintz (5,953,931).
Ratification of Frazier & Deeter as independent auditors approved with 7,162,782 votes for, 90,321 against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.